Outset Medical, Inc. (NasdaqGS: OM)
Health Care · Health Care Equipment & Supplies · US
$4.24
+0.59% today · -69.3% 1Y
Outset Medical, Inc. (NasdaqGS: OM) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $79.14M and employs 310 people.
Over the last twelve months the share price has lost 69.3%, trading between 3.00 and 16.16.
Tweenvest scores Outset Medical, Inc. across four factors: quality 29/100, value 59/100, growth 64/100. Its strongest factor is growth.
OM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $79.14M
- Revenue (TTM)
- $117.80M
- P/E
- —
- EPS
- -4.07
- Dividend yield
- —
- Beta (5Y)
- 1.92
- 52-week high
- $16.16
- 52-week low
- $3.00
- Avg volume (3M)
- —
- Shares outstanding
- 18.80M
- Employees
- 310
- Next earnings
- —
About Outset Medical, Inc.
Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features. Founded in 2003, the company initially operated under the name Home Dialysis Plus, Ltd. before rebranding to Outset Medical, Inc. in January 2015. Its corporate headquarters are located in San Jose, California.
- ISIN
- US6901452069
- Founded
- 2003
- Listed since
- Sep 15, 2020
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $200.95B | $115.18 | -0.82% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.36B | $366.86 | -1.34% |
| Stryker CorporationNYSE: SYK | $126.81B | $331.00 | +0.12% |
| Medtronic plcNYSE: MDT | $116.66B | $91.67 | +0.58% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.36B | €160.50 | +0.85% |
| Boston Scientific CorporationNYSE: BSX | $72.26B | $47.59 | -4.55% |
| HOYA CorporationTSE: 7741 | $52.49B | ¥24,995.00 | +0.40% |
| Edwards Lifesciences CorporationNYSE: EW | $52.38B | $90.76 | -0.12% |
Figures last refreshed Aug 18, 2026.